Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs

Lucia Gatta, Alessio Cardinale, Francesca Wannenes, Claudia Consoli, Andrea Armani, Francesca Molinari, Caterina Mammi, Fabrizio Stocchi, Margherita Torti, Giuseppe M C Rosano, Massimo Fini

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Elevated oxidative stress-induced apoptosis has been found in peripheral cells from patients with Alzheimer's disease (AD). Furthermore, treatment of lymphocytes from AD patients, with Aβ1-42 and H2O2 results in enhanced apoptosis. Mild cognitive impairment (MCI), a clinical condition between normal aging and AD, shares with AD a similar pattern of peripheral markers of oxidative stress. In this study we investigated spontaneous and H2O2-induced oxidative stress and apoptosis levels in peripheral blood mononuclear cells (PBMCs) from MCI and AD patients, as well as from Parkinson's disease (PD) patients without cognitive impairment or age-matched healthy control. Sod1 mRNA levels were studied to analyse the anti-oxidative pathway, while Bax and Bcl-2 mRNAs levels and PARP protein cleavage were monitored to study apoptosis. We found that the expression of Sod1 and Bax mRNAs was statistically higher in both MCI and AD patients compared to controls or PD subjects. Since Bcl-2 mRNA level was not different among groups, the Bax/Bcl-2 ratio was statistically higher in AD and MCI patients. PARP cleavage was also enhanced in PBMCs from MCI and AD individuals and this finding was associated with a higher level of spontaneous apoptosis. Interestingly, exposure to H2O2 induced a significant decrease of Bcl-2 mRNA transcript, while Sod1 and Bax mRNAs levels were unchanged in PBMCs derived from MCI and AD patients. In conclusion, our results show that Bax and Sod1 mRNA levels are altered in PBMCs from both MCI and AD patients and indicate these changes as potential biomarkers in the early diagnosis of AD.

Original languageEnglish
Pages (from-to)36-40
Number of pages5
JournalNeuroscience Letters
Volume453
Issue number1
DOIs
Publication statusPublished - Mar 27 2009

Fingerprint

Blood Cells
Alzheimer Disease
Messenger RNA
Apoptosis
Oxidative Stress
Parkinson Disease
Cognitive Dysfunction
Early Diagnosis
Biomarkers
Lymphocytes

Keywords

  • Alzheimer's disease
  • Apoptosis
  • Mild cognitive impairment
  • Peripheral blood mononuclear cells

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs. / Gatta, Lucia; Cardinale, Alessio; Wannenes, Francesca; Consoli, Claudia; Armani, Andrea; Molinari, Francesca; Mammi, Caterina; Stocchi, Fabrizio; Torti, Margherita; Rosano, Giuseppe M C; Fini, Massimo.

In: Neuroscience Letters, Vol. 453, No. 1, 27.03.2009, p. 36-40.

Research output: Contribution to journalArticle

@article{4ab891b562df42c0aebb5bbab85cfe59,
title = "Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs",
abstract = "Elevated oxidative stress-induced apoptosis has been found in peripheral cells from patients with Alzheimer's disease (AD). Furthermore, treatment of lymphocytes from AD patients, with Aβ1-42 and H2O2 results in enhanced apoptosis. Mild cognitive impairment (MCI), a clinical condition between normal aging and AD, shares with AD a similar pattern of peripheral markers of oxidative stress. In this study we investigated spontaneous and H2O2-induced oxidative stress and apoptosis levels in peripheral blood mononuclear cells (PBMCs) from MCI and AD patients, as well as from Parkinson's disease (PD) patients without cognitive impairment or age-matched healthy control. Sod1 mRNA levels were studied to analyse the anti-oxidative pathway, while Bax and Bcl-2 mRNAs levels and PARP protein cleavage were monitored to study apoptosis. We found that the expression of Sod1 and Bax mRNAs was statistically higher in both MCI and AD patients compared to controls or PD subjects. Since Bcl-2 mRNA level was not different among groups, the Bax/Bcl-2 ratio was statistically higher in AD and MCI patients. PARP cleavage was also enhanced in PBMCs from MCI and AD individuals and this finding was associated with a higher level of spontaneous apoptosis. Interestingly, exposure to H2O2 induced a significant decrease of Bcl-2 mRNA transcript, while Sod1 and Bax mRNAs levels were unchanged in PBMCs derived from MCI and AD patients. In conclusion, our results show that Bax and Sod1 mRNA levels are altered in PBMCs from both MCI and AD patients and indicate these changes as potential biomarkers in the early diagnosis of AD.",
keywords = "Alzheimer's disease, Apoptosis, Mild cognitive impairment, Peripheral blood mononuclear cells",
author = "Lucia Gatta and Alessio Cardinale and Francesca Wannenes and Claudia Consoli and Andrea Armani and Francesca Molinari and Caterina Mammi and Fabrizio Stocchi and Margherita Torti and Rosano, {Giuseppe M C} and Massimo Fini",
year = "2009",
month = "3",
day = "27",
doi = "10.1016/j.neulet.2009.02.003",
language = "English",
volume = "453",
pages = "36--40",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs

AU - Gatta, Lucia

AU - Cardinale, Alessio

AU - Wannenes, Francesca

AU - Consoli, Claudia

AU - Armani, Andrea

AU - Molinari, Francesca

AU - Mammi, Caterina

AU - Stocchi, Fabrizio

AU - Torti, Margherita

AU - Rosano, Giuseppe M C

AU - Fini, Massimo

PY - 2009/3/27

Y1 - 2009/3/27

N2 - Elevated oxidative stress-induced apoptosis has been found in peripheral cells from patients with Alzheimer's disease (AD). Furthermore, treatment of lymphocytes from AD patients, with Aβ1-42 and H2O2 results in enhanced apoptosis. Mild cognitive impairment (MCI), a clinical condition between normal aging and AD, shares with AD a similar pattern of peripheral markers of oxidative stress. In this study we investigated spontaneous and H2O2-induced oxidative stress and apoptosis levels in peripheral blood mononuclear cells (PBMCs) from MCI and AD patients, as well as from Parkinson's disease (PD) patients without cognitive impairment or age-matched healthy control. Sod1 mRNA levels were studied to analyse the anti-oxidative pathway, while Bax and Bcl-2 mRNAs levels and PARP protein cleavage were monitored to study apoptosis. We found that the expression of Sod1 and Bax mRNAs was statistically higher in both MCI and AD patients compared to controls or PD subjects. Since Bcl-2 mRNA level was not different among groups, the Bax/Bcl-2 ratio was statistically higher in AD and MCI patients. PARP cleavage was also enhanced in PBMCs from MCI and AD individuals and this finding was associated with a higher level of spontaneous apoptosis. Interestingly, exposure to H2O2 induced a significant decrease of Bcl-2 mRNA transcript, while Sod1 and Bax mRNAs levels were unchanged in PBMCs derived from MCI and AD patients. In conclusion, our results show that Bax and Sod1 mRNA levels are altered in PBMCs from both MCI and AD patients and indicate these changes as potential biomarkers in the early diagnosis of AD.

AB - Elevated oxidative stress-induced apoptosis has been found in peripheral cells from patients with Alzheimer's disease (AD). Furthermore, treatment of lymphocytes from AD patients, with Aβ1-42 and H2O2 results in enhanced apoptosis. Mild cognitive impairment (MCI), a clinical condition between normal aging and AD, shares with AD a similar pattern of peripheral markers of oxidative stress. In this study we investigated spontaneous and H2O2-induced oxidative stress and apoptosis levels in peripheral blood mononuclear cells (PBMCs) from MCI and AD patients, as well as from Parkinson's disease (PD) patients without cognitive impairment or age-matched healthy control. Sod1 mRNA levels were studied to analyse the anti-oxidative pathway, while Bax and Bcl-2 mRNAs levels and PARP protein cleavage were monitored to study apoptosis. We found that the expression of Sod1 and Bax mRNAs was statistically higher in both MCI and AD patients compared to controls or PD subjects. Since Bcl-2 mRNA level was not different among groups, the Bax/Bcl-2 ratio was statistically higher in AD and MCI patients. PARP cleavage was also enhanced in PBMCs from MCI and AD individuals and this finding was associated with a higher level of spontaneous apoptosis. Interestingly, exposure to H2O2 induced a significant decrease of Bcl-2 mRNA transcript, while Sod1 and Bax mRNAs levels were unchanged in PBMCs derived from MCI and AD patients. In conclusion, our results show that Bax and Sod1 mRNA levels are altered in PBMCs from both MCI and AD patients and indicate these changes as potential biomarkers in the early diagnosis of AD.

KW - Alzheimer's disease

KW - Apoptosis

KW - Mild cognitive impairment

KW - Peripheral blood mononuclear cells

UR - http://www.scopus.com/inward/record.url?scp=61449196575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449196575&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2009.02.003

DO - 10.1016/j.neulet.2009.02.003

M3 - Article

C2 - 19429011

AN - SCOPUS:61449196575

VL - 453

SP - 36

EP - 40

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -